Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study
BADBIR Study Group, the PSORT Consortium & BSTOP study group, 30 Apr 2026, In: Clinical and Translational Science. 19, 5, p. e70563
Research output: Contribution to journal › Article › peer-review
